Original Article
Development of a predictive model for lymph node metastasis in esophageal cancer using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) semi-quantitative parameters and tumor biomarkers
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2515-2526
.
(31 December 2025)
Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2527-2538
.
(31 December 2025)
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for advanced esophageal and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2539-2552
.
(31 December 2025)
The clinical efficacy and pathological assessment of neoadjuvant imatinib treatment in patients with primary gastrointestinal stromal tumors
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2553-2564
.
(31 December 2025)
mTLS status predicts survival benefit from adjuvant chemotherapy in gastric cancer patients treated with neoadjuvant therapy and surgery
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2565-2583
.
(31 December 2025)
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer—a retrospective cohort study providing real-world survival and safety data from the United Kingdom
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2584-2591
.
(31 December 2025)
Parenteral nutrition versus enteral nutrition after gastric cancer surgery: a systematic review and meta-analysis of randomized controlled trials
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2592-2602
.
(31 December 2025)
Trends of mortality among patients with malignant neoplasms of digestive system in the United States from 2007 to 2021
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2603-2612
.
(31 December 2025)
The effect of neoadjuvant chemoradiotherapy on perioperative outcomes in rectal cancer patients following stoma reversal—a retrospective cohort analysis
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2613-2619
.
(31 December 2025)
The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2620-2631
.
(31 December 2025)
Predicting bevacizumab efficacy: the emerging role of ACTL6B in colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2632-2650
.
(31 December 2025)
A prognostic nomogram for colorectal cancer: integrating blood microbiome and clinical factors
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2651-2663
.
(31 December 2025)
Bibliometric analysis on the correlation between colorectal cancer and tumor microenvironment [2009–2024]
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2664-2685
.
(31 December 2025)
Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2686-2702
.
(31 December 2025)
ZNF454-FSTL3 axis inhibits colorectal cancer progression by inhibiting HIF-1α-mediated glycolysis in hypoxia
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2703-2718
.
(31 December 2025)
Glutaryl-CoA dehydrogenase: a key biomarker linking lysine degradation to hepatocellular carcinoma metastasis and prognosis via NF-KB signaling pathway
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2719-2730
.
(31 December 2025)
Safety and efficacy of transcatheter chemoembolization combined with hepatic arterial infusion chemotherapy for unresectable primary liver cancer: a single-center prospective study
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2731-2740
.
(31 December 2025)
Efficacy and safety of tyrosine kinase inhibitors combined with sintilimab and transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma: a pooled analysis
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2741-2749
.
(31 December 2025)
Predicting the prognosis of hepatocellular carcinoma after curative resection using a nomogram based on the ratio of prealbumin to platelet distribution width
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2750-2774
.
(31 December 2025)
Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2775-2788
.
(31 December 2025)
Survival outcomes of patients after liver transplantation for patients with hepatocellular carcinoma exceeding the Hangzhou criteria
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2789-2801
.
(31 December 2025)
Landscape targeted of therapy in advanced pancreatic adenocarcinoma: a network meta-analysis of randomized controlled trials [2010–2024]
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2802-2813
.
(31 December 2025)
Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2814-2826
.
(31 December 2025)
The value of lipid metabolism-related genes in pancreatic cancer immunotherapy and drug prediction
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2827-2846
.
(31 December 2025)
Lumbar centroid level subcutaneous fat volume increased performance of prognostic predictive model in digestive system cancers: a real-world cohort study
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2847-2863
.
(31 December 2025)
Case Report
Hypercalcemia in metastatic pancreatic neuroendocrine tumor: a case report of ectopic 1,25 hydroxyvitamin D production by tumor cells and tumor-associated macrophages
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2864-2872
.
(31 December 2025)
Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2873-2880
.
(31 December 2025)
Multidisciplinary team approach of treatment of a metastatic gastric carcinoma during pregnancy: a case report
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2881-2886
.
(31 December 2025)
Intraocular metastasis from an anal squamous cell carcinoma: a case report
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2887-2890
.
(31 December 2025)
Editorial
Claudin 18.2 in gastroesophageal adenocarcinoma: prevalence, biomarker associations, and implications for equity
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2891-2894
.
(31 December 2025)
Editorial Commentary
Right place right time: the role of immunotherapy in patients with locally advanced gastric/gastroesophageal junction adenocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2895-2899
.
(31 December 2025)
Potential of regorafenib in late-line treatment for refractory advanced gastric cancer
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2900-2904
.
(31 December 2025)
Erratum
Erratum: The clinical value of spectral computed tomography reconstruction technology for the anatomy of the superior mesenteric artery in laparoscopic radical right hemicolectomy for colon cancer: a cross-sectional study
Journal of Gastrointestinal Oncology
2025;
16
(6)
:2905-2906
.
(31 December 2025)
